Narrow therapeutic index drugs require stricter bioequivalence standards to prevent dangerous side effects or treatment failure. Learn how the FDA, EMA, and Health Canada regulate generics of critical medications like warfarin and levothyroxine.
Narrow therapeutic index drugs require extreme precision in dosing. Learn why generic versions can be risky, how the FDA regulates them, and what steps you can take to stay safe when switching medications.